环孢素A+甲氨蝶呤+霉酚酸酯+抗胸腺细胞球蛋白四联方案预防无关供体造血干细胞移植中的移植物抗宿主病 |
| |
摘 要: |
|
关 键 词: | 环孢素 甲氨蝶呤 霉酚酸酯 抗胸腺细胞球蛋白 四联方案 预防 无关供体造血干细胞移植 移植物抗宿主病 白血病 |
Quadruple therapy with CsA, MTX, MMF and ATG for preventing graft-versus-host disease in unrelated donor hematopoietic stem cell transplantation] |
| |
Authors: | Qi-fa Liu Jing Sun Yu Zhang Dan Xu Xiao-li Liu Bing Xu Fan-yi Meng Shu-yun Zhou |
| |
Institution: | Department of Hematology, Nanfang Hospital, First Military Medical University, Guangzhou 510515, China. liuqifa@fimmu.com |
| |
Abstract: | OBJECTIVE: To evaluate the efficacy of quadruple therapy with cyclosporine (CsA), methotrexate (MTX), mycophenolate mofetil (MMF) and low-dose antithymocyte globulin (ATG) for graft-versus-host disease (GVHD) prophylaxis in unrelated donor hematopoietic stem cell transplantation (URD-HSCT). METHODS: Thirteen patients with leukemia received URD-HSCT, of whom 11 had HLA genotypes and 2 had mismatch for 1 genetic locus. Another 11 leukemia patients all serologically matched underwent related donor (RD)-HSCT. Total body irradiation (TBI) plus cyclophosphamide (CTX) was adopted in 19 cases and modified BuCY conditioning regimen (hydroxyurea, busulfan, Ara-C, Cyclophosphamide ) in the other 5 cases. All the patients received CsA+MTX protocal for GVHD prophylaxis, and in those undergoing URD-HSCT, additional MMF and low-dose ATG were used. RESULTS: The incidence and severity of regimen-related toxicity differed little between unrelated and related transplantation. Acute GVHD (aGVHD) occurred in 46.2% of the patients undergoing URD- HSCT and in 55.6% of those with RD-HSCT, respectively. Four patients had chronic GVHD (cGVHD), in the 7 ones who could be followed up after URD-HSCT; 6 of the 9 patients with RD-HSCT developed cGVHD postoperatively. One patient with URD-HSCT died of hemorrhagic cystitis and another with RD-HSCT died of cytomegalovirus (CMV) pneumonia. The at one-year disease-free survival rate was 87.5% and 90.9% in patients with unrelated and related transplantation respectively. Significant difference was not noted in the positivity rate of CMV antigen between the patients receiving URD-HSCT or RD-HSCT. CONCLUSION: CsA+MTX in combination with MMF and low-dose ATG may decrease the incidence and severity of aGVHD without increasing transplant-related mortality or CMV infection. |
| |
Keywords: | |
|
|